Twist Bioscience (TWST): President and COO Finn Patrick John sold $302,152 worth of shares (2,245 units at $134.59) (SEC Form 4)

Historical context for TWST

Across the 24 sessions after earlier TWST headlines, the stock closed higher 15 times and lower 9 times, with a median move of 3.7% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.

Earlier insider filings at TWST

• Oct 13, 2026Chief Financial Officer Laponis Adam sold $384,823 worth of shares (2,462 units at $156.30) (SEC Form 4)
• Oct 7, 2026Chief Executive Officer Leproust Emily M. sold $919,374 worth of shares (4,548 units at $202.15) as part of a pre-agreed trading plan (SEC Form 4)
• Oct 5, 2026Chief Financial Officer Laponis Adam sold $1,521,838 worth of shares (8,057 units at $188.88) (SEC Form 4)
• Oct 5, 2026Chief Executive Officer Leproust Emily M. sold $8,769,799 worth of shares (46,391 units at $189.04) as part of a pre-agreed trading plan (SEC Form 4)
• Oct 5, 2026President and COO Finn Patrick John sold $4,856,963 worth of shares (25,714 units at $188.88) (SEC Form 4)